S. Saks
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 7
- Chronic Lymphocytic Leukemia Research 5
- Hemoglobinopathies and Related Disorders 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Jordan U. Gutterman (8 shared papers)Razelle Kurzrock (6 shared papers)Moshe Talpaz (5 shared papers)Bruce A. Feinberg (2 shared papers)Mark Blick (1 shared paper)Henry H. Roenigk (1 shared paper)D. B. Norris (1 shared paper)Steven T. Rosen (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Blood (2 papers)Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
S. Saks
20 papers receiving 783 citations
Peers
Comparison fields: 5 of 74
- Immunology 313
- Hematology 164
- Dermatology 117
- Genetics 132
- Oncology 258
Countries citing papers authored by S. Saks
This map shows the geographic impact of S. Saks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Saks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Saks more than expected).
Fields of papers citing papers by S. Saks
This network shows the impact of papers produced by S. Saks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Saks. The network helps show where S. Saks may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Saks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 184 | |
| 2 | 1990 | 126 | |
| 3 | 1987 | 75 | |
| 4 | Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer. | 1989 | 58 |
| 5 | Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. | 1989 | 43 |
| 6 | 1985 | 41 | |
| 7 | 1988 | 40 | |
| 8 | The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer. | 1990 | 39 |
| 9 | Recombinant human TNF-alpha: preclinical studies and results from early clinical trials. | 1992 | 34 |
| 10 | Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma. | 1988 | 22 |
| 11 | 1989 | 21 | |
| 12 | 2024 | 21 | |
| 13 | 1991 | 20 | |
| 14 | 1987 | 18 | |
| 15 | 2022 | 18 | |
| 16 | Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. | 1985 | 17 |
| 17 | A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. | 1990 | 16 |
| 18 | Phase I and II studies of the combination of recombinant human interferon-gamma and 5-fluorouracil in patients with advanced colorectal carcinoma. | 1989 | 14 |
| 19 | Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinoma. | 1989 | 7 |
| 20 | 1987 | 1 |
About S. Saks
S. Saks is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Rheumatology, having authored 20 papers that have together received 815 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Cancer Research and Treatments (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Immunology (313 citations), Hematology (164 citations), Dermatology (117 citations), Genetics (132 citations) and Oncology (258 citations). S. Saks has collaborated with scholars based in United States. Frequent co-authors include Jordan U. Gutterman, Razelle Kurzrock, Moshe Talpaz, Bruce A. Feinberg, Mark Blick, Henry H. Roenigk, D. B. Norris, Steven T. Rosen, Paul A. Bunn and Edward H. Kaplan. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, JNCI Journal of the National Cancer Institute and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.